Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet
Marketer
Jubilant Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet
Diabexe Trio (1mg/500mg/0.3mg) tablets are an antidiabetic combination medication for adult type 2 diabetes management. This formulation helps regulate blood glucose. Administer Diabexe Trio with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision loss, neuropathy, and limb problems. Remember, Diabexe Trio is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry a fast-acting glucose source (e.g., sugary snacks or juice), and limit alcohol consumption to mitigate this risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Diabexe Trio is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Uses of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet works:
Jubiglim MV1 Plus tablets (1mg/500mg/0.3mg) contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablets is contraindicated in those with severe kidney impairment.
LiverCAUTION
Patients with liver disease should use Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet cautiously, potentially requiring dosage modification. A physician's consultation is recommended. In those with mild to moderate liver impairment, initiation should be at a low dose; however, it's contraindicated for patients with severe hepatic dysfunction.
What if you forget to take Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet :
Should you forget a Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet dose, administer it promptly. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently